Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Cash Flow-to-Debt Ratio
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow-to-Debt Ratio of 0.23x as of December 2024, meaning its operating cash flow of CN¥47.07 Million could theoretically repay 0% of its total liabilities (CN¥200.84 Million) in one year. See Suzhou Fushilai Pharmaceutical Co. Ltd. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year debt coverage analysis for Suzhou Fushilai Pharmaceutical Co. Ltd.. Check Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | CN¥47.07 Million | CN¥200.84 Million | ▼ -57.8% |
| 2023 | 0.56x | CN¥94.77 Million | CN¥170.45 Million | ▼ -22.1% |
| 2022 | 0.71x | CN¥151.19 Million | CN¥211.75 Million | ▼ -18.7% |
| 2021 | 0.88x | CN¥199.73 Million | CN¥227.47 Million | ▼ -12.8% |
| 2020 | 1.01x | CN¥166.85 Million | CN¥165.61 Million | ▲ +13.4% |
| 2019 | 0.89x | CN¥150.55 Million | CN¥169.48 Million | — |